肿瘤类器官在药物筛选和个性化用药中的研究进展  

Progress in the Research and Application of Tumor Organoids in Drug Screening and Personalized Drug Treatment

作　　者：杨换连 邱飞[1,2,3] 王国权 刁勇[1,2,3] YANG Huan-lian;QIU Fei;WANG Guo-quan;DIAO Yong(School of Medicine,Huaqiao University,Quanzhou 362021,China;School of Biomedical Sciences,Huaqiao University,Quanzhou 362021,China;Engineering Research Center for Molecular Medicine of Ministry of Education,Quanzhou 362021,China)

机构地区：[1]华侨大学医学院,泉州362021 [2]华侨大学生物医学学院,泉州362021 [3]分子药物教育部工程研究中心,泉州362021

出　　处：《中国生物工程杂志》2022年第6期47-53,共7页China Biotechnology

基　　金：福建省自然科学基金(2018J01127)资助项目。

摘　　要：恶性肿瘤是影响人类生命健康的重大疾病之一,药物治疗是常见的治疗手段。近年来,“精准治疗”已经成为肿瘤治疗的趋势。要实现对恶性肿瘤有效、精准的药物治疗,药物筛选模型至关重要。肿瘤类器官是近年来新兴的一种三维细胞模型,具有经长期传代还保留亲本肿瘤的特征和异质性、培养成功率高、周期短和能够高通量筛选药物等优点,已被用于药物筛选、预测患者对治疗的反应以及为个性化用药提供指导等。重点介绍了肿瘤类器官在药物筛选及个性化用药中的研究进展和面临的挑战。Malignant tumor is one of the major diseases that threaten human life,and drug therapy is a common method.Currently,precision treatment has become a trend of tumor therapy.To achieve effective and precise drug therapy for malignant tumors,the drug screening models are very important points.Tumor organoids are three-dimensional cell models which have emerged in recent years.They have the advantages of retaining the characteristics and heterogeneity of parental tumors during long-term culture,with high success rate of culture and short culture cycle,and they can be used for high-throughput drug screening.They have been used for drug screening,predicting patients’response of drug therapy,and providing guidance for personalized drug treatment.The progress of tumor organoids in drug screening and personalized drug treatment,and possible challenges were introduced.

关 键 词：肿瘤类器官 药物筛选 个性化用药 精准治疗 肿瘤 

分 类 号：R965[医药卫生—药理学]